top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
49884-0125-91 | J7527 | EVEROLIMUS, ORAL, 0. 25 MG | EVEROLIMUS (4X7) 5 MG | PO |
49884-0127-91 | J7527 | EVEROLIMUS, ORAL, 0. 25 MG | EVEROLIMUS (4X7) 7.5 MG | PO |
49884-0158-02 | J7527 | EVEROLIMUS, ORAL, 0.25 MG | EVEROLIMUS (6X10) 0.25 MG | PO |
49884-0159-02 | J7527 | EVEROLIMUS, ORAL, 0.25 MG | EVEROLIMUS (6X10) 0.5 MG | PO |
49884-0160-02 | J7527 | EVEROLIMUS, ORAL, 0.25 MG | EVEROLIMUS (6X10) 0.75 MG | PO |
49884-0283-02 | J7527 | EVEROLIMUS, ORAL, 0. 25 MG | EVEROLIMUS (6X10) 1 MG | PO |
49884-0289-01 | J8999 | PRESCRIPTION DRUG, ORAL, CHEMOTHERAPEUTIC, NOS | MEGESTROL ACETATE 20 MG | PO |
49884-0290-01 | J8999 | PRESCRIPTION DRUG, ORAL, CHEMOTHERAPEUTIC, NOS | MEGESTROL ACETATE 40 MG | PO |
49884-0290-04 | J8999 | PRESCRIPTION DRUG, ORAL, CHEMOTHERAPEUTIC, NOS | MEGESTROL ACETATE 40 MG | PO |
49884-0290-05 | J8999 | PRESCRIPTION DRUG, ORAL, CHEMOTHERAPEUTIC, NOS | MEGESTROL ACETATE 40 MG | PO |
43598-0682-35 | Q2050 | INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG | DOXORUBICIN HCL LIPOSOME NOVAPLUS 2 MG/1 ML | IV |
43598-0683-25 | Q2050 | INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG | DOXORUBICIN HCL LIPOSOME NOVAPLUS 2 MG/1 ML | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
